Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy.
- Resource Type
- Article
- Authors
- Vansteenkiste, Johan; Pirker, Robert; Massuti, Bartomeu; Barata, Fernando; Font, Albert; Fiegl, Michael; Siena, Salvatore; Gateley, Jenni; Tomita, Dianne; Colowick, Alan B.; Musil, Jaromir
- Source
- JNCI: Journal of the National Cancer Institute. 8/21/2002, Vol. 94 Issue 16, p1211. 10p. 1 Diagram, 1 Chart, 7 Graphs.
- Subject
- *LUNG cancer
*CLINICAL trials
*ANTINEOPLASTIC agents
- Language
- ISSN
- 0027-8874
Compares the safety and efficacy of darbepoetin alfa in lung cancer patients receiving chemotherapy. Confidence interval; Blood transfusion requirements; Hemoglobin concentration; Hematopoietic response.